Simply Oncology

Episode 19: Patient Fundamentals - Breast cancer -Discussing CDK4/6 inhibitors in breast cancer for patients with Professor Mark Beresford.

John McGrane & Michael Rowe

Send us a text

In this episode we discuss CDK4/6 inhibitors with Professor Mark Beresford, Clinical oncologist and chair of UK Breast cancer Group.

Mark shares his knowledge on why we are giving these drugs to patients with breast cancer and what patients can expect on them.
This is a really big group of patients and we hope this is useful for supporting them.

We hope you enjoy

John & Mike

People on this episode